PYXS (STOCKS)
Pyxis Oncology, Inc. Common Stock
$1.710000
+0.010000 (+0.59%)
Prev close: $1.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas Civik
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $107.76M
- Employees
- 44
- P/E (TTM)
- -1.33
- P/B (TTM)
- 2.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.29 | $-0.34 | +0.0534 | +15.55% |
|
Sep 2025 (Q3)
|
$-0.35 | $-0.35 | -0.0047 | -1.36% |
|
Jun 2025 (Q2)
|
$-0.30 | $-0.36 | +0.0587 | +16.36% |
|
Mar 2025 (Q1)
|
$-0.35 | $-0.30 | -0.0501 | -16.71% |
Financial Statements
| Revenues | $13.86M |
| Benefits Costs and Expenses | $92.09M |
| Cost Of Revenue | $2.39M |
| Costs And Expenses | $92.09M |
| Gross Profit | $11.47M |
| Nonoperating Income/Loss | $6.19M |
| Operating Expenses | $95.89M |
| Research and Development | $73.70M |
| Other Operating Expenses | $22.19M |
| Operating Income/Loss | -$84.42M |
| Income/Loss From Continuing Operations After Tax | -$79.62M |
| Income/Loss From Continuing Operations Before Tax | -$78.24M |
| Income Tax Expense/Benefit | $1.39M |
| Income Tax Expense/Benefit, Current | $1.39M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$79.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$79.62M |
| Net Income/Loss Available To Common Stockholders, Basic | -$79.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.28 |
| Diluted Earnings Per Share | -$1.28 |
| Basic Average Shares | 62,143,166 |
| Diluted Average Shares | 62,143,166 |
| Assets | $91.52M |
| Current Assets | $72.11M |
| Cash | $66.90M |
| Prepaid Expenses | $3.78M |
| Other Current Assets | $1.43M |
| Noncurrent Assets | $19.42M |
| Fixed Assets | $8.00M |
| Intangible Assets | $0.00 |
| Other Non-current Assets | $11.42M |
| Liabilities | $38.11M |
| Current Liabilities | $21.13M |
| Accounts Payable | $10.89M |
| Wages | $3.32M |
| Other Current Liabilities | $6.93M |
| Noncurrent Liabilities | $16.98M |
| Equity | $53.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $53.41M |
| Liabilities And Equity | $91.52M |
| Net Cash Flow From Operating Activities | -$63.50M |
| Net Cash Flow From Operating Activities, Continuing | -$63.50M |
| Net Cash Flow From Investing Activities | $58.86M |
| Net Cash Flow From Investing Activities, Continuing | $58.86M |
| Net Cash Flow From Financing Activities | $594.00K |
| Net Cash Flow From Financing Activities, Continuing | $594.00K |
| Net Cash Flow | -$4.05M |
| Net Cash Flow, Continuing | -$4.05M |
| Comprehensive Income/Loss | -$79.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$79.74M |
| Other Comprehensive Income/Loss | -$117.00K |